Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepiness

Pharmaceutical major Lupin on Friday announced that it has received approval from the United States Food and Drug Administration (USFDA) to market Modafinil tablets which are used to treat excessive sleepiness.

According to the company’s statement, it received approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP in 100 mg and 200 mg strengths.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.